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Trichloroethylene (TCE; C2HCl3) is a chlori-
nated hydrocarbon used predominantly as an
industrial degreasing agent and solvent
(Armstrong and Green 2004; Waters et al.
1977; Wu and Schaum 2000). Human expo-
sures are widespread, and TCE is a major
contaminant in agricultural and urban soils
and in groundwater (Wallace et al. 1987; Wu
and Schaum 2000). The current U.S.
Environmental Protection Agency (EPA)
maximum contaminant level (MCL) for TCE
in drinking water is 5 ppb (U.S. EPA 2004).
TCE levels in contaminated water supplies
have exceeded 230 ppb [Goldberg et al. 1990;
Massachusetts Department of Public Health
(MDPH) 1996]. Chlorination of water sup-
plies generates several TCE metabolites, includ-
ing chloral hydrate, trichloroacetic acid (TCA),
and dichloroacetic acid (Miller and Uden
1983). These metabolites are also formed
in vivo from TCE. Because most public water
systems in the United States use chlorine for
disinfection (U.S. EPA 1997), exposures to
these metabolites can be signiﬁcant.
There is lively debate whether maternal
exposure to TCE and related compounds
increases the risk for congenital heart defects
(CHDs) in the offspring. Human epidemio-
logic studies are limited and inconclusive (Bove
et al. 1995; Goldberg et al. 1990; MDPH
1996; Shaw et al. 1990, 1992; Yauck et al.
2004). The most common CHDs reported
involve valvuloseptal structures and include
ventricular and atrial septal defects and aortic
and pulmonary valve stenosis (Goldberg et al.
1990; Yauck et al. 2004).
Results from animal studies are also con-
tradictory. Some report no effect of TCE
exposure (Dorfmueller et al. 1979; Fisher
et al. 2001; Schwetz et al. 1975), whereas
others report a higher incidence of CHDs,
especially those of valvuloseptal origin
(Dawson et al. 1990, 1993; Johnson et al.
1998a, 2003). Valvuloseptal deficits also
occur in an avian embryo model of TCE
exposure (Loeber et al. 1988). The mecha-
nism(s) by which TCE would cause CHDs is
under investigation. TCE may directly target
valvuloseptal formation; in a chick atrio-
ventricular canal (AVC) explant system,
250 ppm TCE significantly inhibited the
epithelial–mesenchymal cell transformation
that underlies chamber septation and valve
formation (Boyer et al. 2000). TCE exposure
also alters the expression of several genes crit-
ical for heart development (Boyer et al. 2000;
Collier et al. 2003; Ou et al. 2003; Selmin
et al. 2005).
The heart develops as a linear tube, com-
posed of an inner endocardium and an outer
myocardium that is separated by an extra-
cellular matrix. Shortly thereafter, the matrix
at two sites within the heart tube, the outﬂow
tract (OFT) and AVC, becomes cellularized to
form “cardiac cushions” (Person et al. 2005).
During this process, endocardial cells respond
to myocardial signals and migrate from the
endocardium into the extracellular matrix,
where they adopt a mesenchymal phenotype
in a process called epithelial-to-mesenchymal
transformation. These mesenchymal cells fur-
ther differentiate into the cardiac valves and
membranous septa. The cushions themselves
function as early valves to control circulation.
We examined TCE’s effects upon valvulo-
septal formation using an established in ovo
chick embryo model (Drake et al. 2006).
Exposure was targeted to the period of cushion
morphogenesis; studies of cardiomyogenesis
will be reported separately (Drake VJ,
Koprowski SL, Smith SM, Lough J, unpub-
lished data). Here, we report that TCE expo-
sure at 4 nmol/egg (8 ppb), a dose slightly
above the current U.S. EPA MCL for drinking
water (5 ppb; U.S. EPA 2004), adversely
affects cushion development, cardiac function,
and embryo survival. Equimolar exposure to
TCA and trichloroethanol (TCOH) had simi-
lar consequences.
Materials and Methods
Animals. All studies used fertile white leghorn
chicken eggs, Babcock strain (University of
Wisconsin–Madison) except that the cardio-
vascular function studies, performed at the
University of Utah, used fertile white leghorn
eggs, Bovan strain (Utah State University,
Logan, UT). We found no differences in the
TCE responses of these strains (Drake VJ,
Koprowski SL, Smith SM, Lough J, unpub-
lished data). Eggs were incubated at 37.5°C
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It is controversial whether trichloroethylene (TCE) is a cardiac teratogen. We exposed chick
embryos to 0, 0.4, 8, or 400 ppb TCE/egg during the period of cardiac valvuloseptal morpho-
genesis (2–3.3 days’ incubation). Embryo survival, valvuloseptal cellularity, and cardiac hemo-
dynamics were evaluated at times thereafter. TCE at 8 and 400 ppb/egg reduced embryo survival
to day 6.25 incubation by 40–50%. At day 4.25, increased proliferation and hypercellularity were
observed within the atrioventricular and outflow tract primordia after 8 and 400 ppb TCE.
Doppler ultrasound revealed that the dorsal aortic and atrioventricular blood ﬂows were reduced
by 23% and 30%, respectively, after exposure to 8 ppb TCE. Equimolar trichloroacetic acid
(TCA) was more potent than TCE with respect to increasing mortality and causing valvuloseptal
hypercellularity. These results independently conﬁrm that TCE disrupts cardiac development of
the chick embryo and identiﬁes valvuloseptal development as a period of sensitivity. The hyper-
cellular valvuloseptal profile is consistent with valvuloseptal heart defects associated with TCE
exposure. This is the ﬁrst report that TCA is a cardioteratogen for the chick and the ﬁrst report
that TCE exposure depresses cardiac function. Valvuloseptal hypercellularity may narrow the car-
diac oriﬁces, which reduces blood ﬂow through the heart, thereby compromising cardiac output
and contributing to increased mortality. The altered valvuloseptal formation and reduced hemo-
dynamics seen here are consistent with such an outcome. Notably, these effects were observed at a
TCE exposure (8 ppb) that is only slightly higher than the U.S. Environmental Protection Agency
maximum containment level for drinking water (5 ppb). Key words: cardiac cushions, chick
embryo, Doppler ultrasound, heart development, proliferation, trichloroethylene. Environ Health
Perspect 114:842–847 (2006). doi:10.1289/ehp.8781 available via http://dx.doi.org/ [Online
9 February 2006]and 70% relative humidity. Embryos were
staged using established criteria (Hamburger
and Hamilton 1951). Embryos did not
develop past day 6.25 and did not experience
pain or suffering.
Materials. TCE, TCOH, or TCA (all
from Sigma-Aldrich, St. Louis, MO) was dis-
solved in prewarmed (50°C) phosphate-
buffered saline (PBS) to give a 1 mM stock
concentration. These stock solutions were sub-
sequently diluted in prewarmed PBS and their
pH adjusted to 7.4. Solutions were prepared
fresh immediately before each experiment.
Embryonic TCE exposure. We used an
established model of in ovo teratogen adminis-
tration in which the teratogen is directly
injected into the center of the yolk via a hole at
the egg’s blunt end. This method does not
cause developmental anomalies in control
embryos (Drake et al. 2006). We used a
repeated-exposures protocol to simulate the
repeated, modest TCE exposures that a human
embryo might experience. Embryos received a
total of four injections of TCE or carrier sol-
vent PBS at Hamburger and Hamilton (HH)
stages HH13, HH15, HH17, and HH20
(2–3.3 days of incubation; Figure 1). These
treatment times spanned the major events of
cardiac cushion formation, from cushion
induction through mesenchyme transforma-
tion and migration. We tested three TCE
doses that bracket the U.S. EPA MCL:
0.4 ppb, 8 ppb, and 400 ppb (Table 1). Each
dose was divided into four 50 μL exposures:
0 nmol/injection (PBS vehicle, 0 nmol total),
0.05 nmol/injection (0.2 nmol total),
1.0 nmol/injection (4 nmol total), and
50 nmol/injection (200 nmol total). Some
embryos instead received TCOH or TCA at a
dose of 1.0 nmol/injection (4 nmol total).
After each injection, the hole was sealed and
the eggs reincubated.
Apoptosis assessment. HH24 embryos were
sectioned to consistently visualize the OFT and
AVC cushions at the level of the atrial septum
and the incipient superior–inferior cushion
fusion, respectively. Cushion morphogenesis is
largely complete by HH24, and the cushions
function as rudimentary valves. Apoptotic cells
were detected using a modified terminal
deoxynucleotidyl transferase-mediated dUTP
nick end-labeling (TUNEL) protocol (Gavrieli
et al. 1992); nicked DNA was end-labeled via
5-bromo-2´-deoxyuridine 5´-triphosphate
(BrdU; Sigma-Aldrich) incorporation and visu-
alized by immunostaining with anti–BrdU
antibody (G3G4; Developmental Studies
Hybridoma Bank, Iowa City, IA) and Alexa
Fluor 488–conjugated antibody (Molecular
Probes, Eugene, OR). All nuclei were visual-
ized by propidium iodide (PI) counterstaining.
The percentage of TUNEL-positive nuclei in
the OFT and AVC mesenchymal nuclei was
determined by treatment-blinded observers.
Care was taken to exclude myocytes and endo-
cardiocytes. Two sections per cushion compris-
ing approximately 300 OFT or AVC cells per
section were counted.
Cellularity and proliferation assessment.
BrdU (50 μL of 10 mM stock) was directly
applied to HH24 embryos in ovo; 4 hr later,
embryos were fixed, and incorporated BrdU
was detected as previously described (Wendler
et al. 2003). Sections through the OFT and
AVC cushions were prepared as described
above for the apoptosis studies. We deter-
mined the percentage of proliferating cushion
mesenchymal cells for each embryo by count-
ing the number of BrdU-labeled and PI-
labeled cells in two sections each through the
OFT (> 200 cells/section) and the AVC
(> 300 cells/section) cushions. All counts were
made at the same position within each heart,
at the level of the atrial septum for the OFT
and at the level of incipient superior–inferior
cushion fusion for the AVC. We excluded
myocytes and endocardiocytes. To ascertain
the overall cushion cellularity, PI-labeled cells
were counted in these two sections and in two
additional, adjacent cranial and caudal sections
(total of six sections per heart region), with a
mean total of approximately 1,300 OFT cells
and approximately 1,700 AVC cells per
embryo.
Hemodynamic assessment. Cardiovascular
effects of TCE exposure were assessed at
HH24 using established methodology (Clark
et al. 1986; Hu and Clark 1989). In brief, the
egg was positioned blunt end up on a micro-
scope stage. The shell and overlying mem-
branes were removed to expose the embryo.
Dorsal aortic and atrioventricular blood veloci-
ties were measured with a 20-MHz pulsed-
Doppler velocity meter (model 545C-3;
Department of Bioengineering, University of
Iowa, Iowa City, IA). Dorsal aortic blood
velocity was obtained by positioning a
0.75-mm piezoelectric crystal at a 45° angle
above the dorsal aorta adjacent to the sinus
venosus. Atrioventricular blood velocity was
recorded by positioning the crystal at the apex
of the ventricle, pointing toward the atrioven-
tricular oriﬁce. Analog waveforms were sam-
pled digitally at 500 Hz via an analog-to-digital
board (AT-MIO16; National Instruments,
Austin, TX) and viewed with custom analysis
software (Labview; National Instruments).
Data were analyzed over ﬁve consecutive
cardiac cycles for each embryo, and heart rate
(beats per min) was determined from the
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Table 1. TCE exposure per egg and the conversion factors.
Amount per injection Total amount of TCE injected per egg
(× 4 injections) ppb/egg nmol/egg Concentration (nM)a
0.1 ppb or 0.05 nmol 0.4 0.2 3
2 ppb or 1 nmol 8.0 4.0 60
100 ppb or 50 nmol 400 200 3,000
aAssumes a mean egg volume of 66.7 mL.
Figure 1. TCE treatment protocol. TCE was administered four times during cardiac cushion formation, at
stages HH13, HH15, HH17, and HH20. Embryos were assessed at HH24 or HH30.
0
TCE
exposure
Hatch
13
(48 hr)
15
(53 hr)
17
(63 hr)
20
(3.3 days)
24
(4.25 days)
30
(6.25 days)
46
(21 days)
HH stage
(time of
incubation)
Figure 2. Effects of TCE on chick embryo survival at (A) HH24 and (B) HH30. Values shown are mean per-
cent survival (± SE) for embryos exposed to TCE during cardiac cushion formation. Each panel represents
the mean of ﬁve experiments; numbers within bars indicate the total number of embryos. 
*Signiﬁcantly different from 0 nmol treatment (p < 0.01); p-values are given above bars.
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0.0002interval of cardiac cycles. The dorsal aortic
blood ﬂow (cubic millimeters per second) was
calculated by multiplying the integrated
velocity curve and the dorsal aortic cross-sec-
tional area; the latter did not differ between
PBS- and TCE-exposed groups. Dorsal aortic
blood ﬂow includes all blood ejected from the
heart except for 10% that is directed cranially
(Hu and Clark 1989). The stroke volume
index (cubic millimeters per beat) was
obtained as the quotient of dorsal aortic
blood flow against heart rate. The atrioven-
tricular blood velocity of the diastolic filling
has a passive and an active component. The
passive phase emerged from end-systole to the
onset of the a-wave, and the active phase,
from the onset of the a-wave to ventricular
pressure upstroke (Hu et al. 1991). Passive
atrioventricular blood ﬂow (cubic millimeters
per second) was calculated using the equation
[passive component area/(passive + active
areas)] × dorsal aortic blood ﬂow. Active atri-
oventricular blood ﬂow (cubic millimeters per
second) was calculated using the equation
[active component area/(active + passive
areas)] × dorsal aortic blood ﬂow.
Statistical analyses. Values are presented as
mean ± SE. Data sets were examined using
SigmaStat statistical software (version 2.0;
Systat Software Inc., Point Richmond, CA).
Normally distributed data were subjected to
an unpaired, two-tailed t-test employing the
appropriate variance parameter (equal or
unequal variance). Data not normally distrib-
uted were examined using the Mann-Whitney
U-test. We considered p < 0.05 signiﬁcant.
Results
TCE decreased embryo survival. Chick
embryos were exposed to TCE (total of 0.2,
4, or 200 nmol/egg) during cardiac cushion
formation (HH13, HH15, HH17, and
HH20). Twenty-two hours after the last
injection (HH24; 4.25 days’ incubation),
embryo survival, deﬁned as the presence of a
beating heart, was normal for all four treat-
ments (Figure 2A). However, at HH30
(6.25 days’ incubation; Figure 2B), there was
significantly reduced survival for embryos
receiving 4 or 200 nmol TCE/egg. Gross mal-
formations at HH24 and HH30 were rare
and did not differ in frequency or appearance
between the control and experimental groups.
Cardiac cushion morphology and cellu-
larity. TCE-exposed hearts at HH24 were
not grossly dysmorphic. Myocardial wall
thickness and trabeculation were superﬁcially
normal. Because cardiac cushion development
may be sensitive to TCE (Boyer et al. 2000),
we evaluated the cushions in detail. The cellu-
lar morphology of cushion mesenchyme,
cardiomyocytes, and endocardiocytes was
unaffected by TCE exposure for all concen-
trations tested (data not shown). TCE did not
alter the incidence of apoptosis in the AVC
and OFT cushions, except at the 200 nmol
dose, which caused a modest but significant
increase in the OFT mesenchyme (Table 2).
In contrast, TCE exposure at 4 nmol/egg sig-
niﬁcantly increased the proliferative index in
the OFT and AVC cushion mesenchyme
(Figure 3A,B). Exposure to 200 nmol
TCE/egg also increased proliferation in the
AVC cushion (p = 0.009) but not in the OFT
(p = 0.185). The increased cushion mesen-
chyme proliferation was translated into
significant cushion hypercellularity for both
the OFT and AVC of TCE-exposed embryos
(Figure 3C,D).
Effects of TCE metabolites. TCE metabo-
lites such as TCA are also reported to be car-
diac teratogens (Johnson et al. 1998a), and
some propose that the proximate teratogen of
TCE exposure is TCA (Johnson et al. 1998b).
We evaluated the consequences of exposure to
the major TCE metabolites TCOH and TCA
compared with TCE. All metabolites were pro-
vided as sequential 1 nmol doses at HH13,
HH15, HH17, and HH20 as described above
(4 nmol/egg total). As before (Figure 2B),
4 nmol/egg TCE reduced embryonic sur-
vival when assessed at HH30 (Figure 4A).
Equimolar exposure to TCOH similarly
reduced embryo survival at HH30. An equiva-
lent TCA dose caused the greatest reduction in
embryo survival (p < 0.001) and was more
potent in this aspect than was TCE (p = 0.041)
or TCOH (p = 0.003).
Mesenchymal cell proliferation within
the cardiac cushions was assessed in HH24
embryos exposed to these metabolites.
Exposure to 4 nmol TCA, but not TCOH,
signiﬁcantly increased cell proliferation in the
OFT (Figure 4B) and AVC (Figure 4C)
cushions to levels similar to those caused by
the parent compound TCE. This increased
proliferation was accompanied by increased
OFT and AVC cushion hypercellularity
(Figure 4D,E). 
TCE exposure alters cardiac hemo-
dynamics. The cushion hypercellularity and
increased mortality caused by 4 nmol/egg
TCE prompted an evaluation of cardiac
hemodynamics. Pulsed-Doppler assessment of
in ovo hearts was performed at HH24, when
Drake et al.
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Table 2. Effects of TCE exposure on apoptosis in
the cardiac cushions.a
Cushion apoptosis
(% TUNEL-positive cells)
TCE/egg (nmol) OFT AVC 
0 0.529 ± 0.29 0.326 ± 0.15
0.2 1.721 ± 0.61 0.192 ± 0.19
4  1.211 ± 0.39 0.214 ± 0.10
200 2.130 ± 0.55* 0.392 ± 0.21
Values shown are  mean ± SE. 
aExperiments were performed in duplicate; n= 5–10 embryos
per dose. *p < 0.01 versus 0 nmol TCE/egg (Mann-Whitney
U-test).
Figure 3. Effects of TCE on cardiac cushion proliferation and cellularity in HH24 chick embryos. Embryos
were exposed to TCE during cushion development. Percentage of BrdU-labeled cushion mesenchyme in
(A) OFT cushions and (B) AVC cushions. Total mesenchymal cellularity in the (C) OFT cushions and (D) AVC
cushions. Values shown are mean ± SE. Experiments were performed in triplicate; the total number of
embryos evaluated was 8 for 0 nmol, 7 for 0.2 nmol, 10 for 4 nmol, and 9 for 200 nmol.
*Signiﬁcantly different from 0 nmol treatment; p-values are given above bars.
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The hemodynamic parameters (heart rate,
stroke volume, mean blood flow) of PBS-
treated embryos were consistent with previ-
ously published values for HH24 chick
embryos (Broekhuizen et al. 1993; Clark and
Hu 1982; Hu and Clark 1989; Hu et al.
1991); hence, the treatment protocol per se
did not adversely affect cardiac blood ﬂow. In
contrast, TCE exposure altered hemo-
dynamic parameters. Although TCE affected
neither cardiac cycle length (474 ± 18 msec
vs. 431 ± 13 msec, TCE vs. PBS treatment;
p = 0.088) nor heart rate (p = 0.085; Figure
5A), TCE-treated embryos had a 22.9%
reduction in dorsal aortic blood flow
(p = 0.032; Figure 5B–D). Because TCE did
not affect the dorsal aortic diameter (PBS,
0.42 ± 0.008 mm; TCE, 0.42 ± 0.01 mm;
p = 0.78), this decrease could be attributed to
a 30.5% reduction in the active component
of atrioventricular blood flow (0.46 ±
0.05 mm3/sec vs. 0.66 ± 0.04 mm3/sec, TCE
vs. PBS treatment; p = 0.006; Figure 5B,E,F).
The passive-to-active atrioventricular blood
flow ratio also was significantly greater in
TCE-exposed embryos (p = 0.018; Figure 5G).
Additionally, TCE treatment was associated
with a trend toward a lower stroke volume,
although this did not reach statistical signiﬁ-
cance (p = 0.067; Figure 5H). Collectively,
these data show that exposure to 4 nmol TCE
during cushion morphogenesis reduced the
cardiac output of these embryos.
Discussion
In this article we report that exposure to envi-
ronmentally relevant TCE doses during cush-
ion formation altered avian heart development.
These exposures caused signiﬁcant reductions
in intracardiac blood ﬂow and were associated
with increased mortality. These ﬁndings pro-
vide independent conﬁrmation that TCE expo-
sure alters heart development in a manner that
has deleterious, functional consequences. This
work does not address the issue of “selectivity”
because only the heart was examined. The ques-
tion of whether TCE is a cardiac teratogen is
controversial (Hardin et al. 2004; Johnson et al.
2004). With the exception of increased mortal-
ity that was revealed as development progressed
(6.25 vs. 4.25 days’ incubation; Figure 2), the
cardiac anomalies induced by TCE, although
statistically signiﬁcant, were subtle. Moreover,
previous studies of TCE did not evaluate car-
diac function, perhaps because of technologic
limitations. From these considerations, we con-
jecture that subtle cellular alterations that
nonetheless affect cardiac function have been
overlooked until now. Other recent examples
of nonobvious embryonic defects that cause
remarkable cardiac dysfunction at later stages
of development include the disruption of genes
encoding the aryl hydrocarbon receptor
(Thackaberry et al. 2002) and retinol binding
protein (Smith SM, Flentke GR, Lough J,
unpublished data; Wendler et al. 2003).
Our results reinforce previous findings
that cardiac cushion development is adversely
affected by TCE. TCE alters the expression
of rat heart genes, some of which regulate
epithelial–mesenchymal cell transformation in
the cushions (Collier et al. 2003). Substantially
higher TCE concentrations than those studied
here (parts per million vs. parts per billion)
inhibit epithelial detachment and mesenchyme
formation in cultured chick AVC explants
(Boyer et al. 2000), and this may reﬂect overt
toxicity to these cells.
Importantly, depending on the region
affected and its severity, cushion hyperplasia
leads to defects ranging from valvular stenosis,
cardiac regurgitation, and reduced chamber
ﬂow to overt CHDs, including failed atrial or
ventricular septation, aortic or pulmonary aor-
tic stenosis, double-outlet right ventricle, and
transposition of the great arteries (Chen et al.
2000; Costell et al. 2002; Galvin et al. 2000;
Iwamoto et al. 2003; Lakkis and Epstein
1998). These are among the most common
CHDs observed in animals exposed to TCE
and dichloroethylene, which include stenosis of
the atrioventricular, pulmonary, and aortic
valves; aortic and pulmonary artery hypoplasia;
and disrupted atrial and ventricular septation
(Goldberg et al. 1992; Johnson et al. 1998a;
TCE alters heart development and function
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Figure 4. Effects of TCE and its metabolites on embryo survival and cushion development. Embryos were treated with PBS or with 4 nmol/egg of TCE, TCA, or
TCOH during cushion development. (A) Mean embryo survival ± SE at HH30 (n = 3 experiments; values represent 32 embryos for PBS, 46 for TCE, 41 for TCOH, and
34 for TCA). (B and C) Mean cardiac cushion proliferative index ± SE in OFT (B) and AVC (C), assessed at HH24 using BrdU incorporation. (D and E) Mean cushion
cellularity of the OFT (D) and AVC (E). Experiments in B–E were performed in duplicate and represent 7 embryos for PBS, 7 for TCE, 5 for TCOH, and 7 for TCA. 
*Signiﬁcantly different from PBS treatment; p-values are given above bars.Loeber et al. 1988). Although the cause of the
cushion hypercellularity seen here is unknown,
the increased proliferation without a commen-
surate rise in apoptosis is likely contributory.
TCE might also affect cues that induce the
mesenchymal transition of endocardial cells
(Boyer et al. 2000; Collier et al. 2003), or
other participants in valvuloseptal morpho-
genesis, including the neural crest or the
cardiomyocytes themselves. Curiously, the
4 nmol/egg TCE dose, when applied to the
cardiomyogenesis window of chick embryos
(HH3+ to HH17), causes myocyte and endo-
cardiocyte hyperproliferation (Drake VJ,
Koprowski SL, Smith SM, Lough J, unpub-
lished data). This suggests that the TCE-
induced proliferation of cushion mesenchyme
may not be an isolated phenomenon.
The cardiac cushions are critical structures
that arise early during heart morphogenesis to
form the valves, anchor the atrial and ventricu-
lar muscular septa, and divide the OFT into
the aorta and pulmonary artery. They also act
as rudimentary valves that control chamber
ﬁlling, prevent backﬂow, and sustain cardiac
output and arterial pressure. Their function is
critical to embryonic survival because the
embryo’s expanding vascularization in
response to rapid growth requires the heart to
continuously increase its cardiac output and
meet this growing demand (Campbell et al.
1992). Perhaps because the early embryonic
heart is morphologically simple, its structure
can adjust to small changes in hemodynamic
load (Sedmera et al. 1999); in turn, subtle
changes in cardiac structure may cause dispro-
portionate hemodynamic responses. Hence,
the primary defect caused by TCE could be
anatomical or functional. With respect to the
former, as outlined in Figure 6, cushion
hypercellularity would narrow the OFT and
AVC orifices, consequently reducing blood
flow during a time of high growth demand,
thereby causing mortality. Cardiomyocyte
dysfunctions, although not identified, could
be contributory. Changes in flow rate and
pressure would in turn remodel the growing
OFT and AVC septa and valves. Regardless of
the initial target, such changes are often lethal.
The TCE doses studied here may have rel-
evance for environmental exposure. Of the
three doses tested—0.2 nmol/egg (0.4 ppb),
4 nmol/egg (8 ppb), and 200 nmol/egg
(400 ppb)—only the latter, which is a dose
encountered at contaminated sites (Goldberg
et al. 1990; MDPH 1996), appreciably exceeds
the 5 ppb U.S. EPA MCL  (U.S. EPA 2004).
Our study revealed a clear dose–response
threshold: whereas TCE at 0.2 nmol/egg did
not affect cushion formation or embryo sur-
vival, these measures were adversely affected at
the two higher doses. The 4 nmol/egg and
200 nmol/egg doses were largely equipotent,
suggesting that the hyperproliferative response
of cushion cells reached a maximum at the
lower dose. Our 4 nmol/egg dose, adminis-
tered into the yolk, is in a similar range
(0.30–0.75 nmol/egg, applied directly to the
Drake et al.
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Figure 6. Possible consequences of TCE exposure
to cardiac development and function.
Figure 5. Effects of TCE on cardiovascular function at HH24. Embryos were treated with PBS or 4 nmol TCE
during cushion development. Heart rate (A) and mean dorsal aortic and atrioventricular (both passive and
active components for the atrioventricular) blood ﬂow (B) for PBS- and TCE-exposed embryos; values are
mean ± SE for 8 PBS or 11 TCE embryos. (C–F) Representative dorsal aortic (C and D) and atrioventricular (E
and F) velocity analog waveforms for a PBS-treated (C and E) and a TCE-treated (D and F) embryo; TCE
exposure reduced both the dorsal aortic and active atrioventricular velocities. (G and H) Ratio of passive to
active atrioventricular blood ﬂow (G) and stroke volume index (H) for PBS- and TCE-exposed embryos. 
*Signiﬁcantly different from PBS treatment; p-values are given above bars.
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embryo) previously shown to increase CHD in
chick embryos (Loeber et al. 1988). These
doses are lower than those causing CHD in the
mammalian studies (0.25, 1.5, and 1,100 ppm;
Dawson et al. 1990, 1993; Johnson et al.
1998a, 2003), although direct comparison is
difﬁcult because the fetal TCE or TCA content
was not assessed.
Metabolic activation of TCE to TCA may
be necessary for the compound’s cardiac terato-
genicity (Johnson et al. 1998b). Compared
with TCE and TCOH, TCA most potently
decreased embryonic survival (Figure 4A) and
was equipotent with TCE in stimulating cush-
ion mesenchymal cell proliferation. Our results
clearly reinforce previous ﬁndings that TCE is
a cardiac teratogen for chick and extend the
cardioteratogenicity of TCA to this species.
Importantly, this is the ﬁrst demonstration that
developmental TCE exposure adversely affects
the hemodynamic activities of the heart. These
effects occurred at exposures only slightly
above the U.S. EPA MCL for TCE. A parallel
application of technologies that evaluate car-
diac function in utero may offer insights into
the controversy of whether cardiac deficits
occur in mammals receiving gestational TCE
exposure. To that end, we note that thalido-
mide variably perturbs rodent development
but is a potent teratogen for avian and non-
rodent species, including humans (Schardein
2000). Advanced molecular and physiologic
tests across several model species should help
resolve this question for TCE.
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